skip to Main Content

Clinical Evidence and Research Support LinQ Posterior SI Joint Fusion as:

Simple

A single allograft implant, small incision, and streamlined 4-step procedure leads to reduced procedure time and hospital stay.

Safe

A posterior approach away from major nerves and arteries, and monitored sedation support fewer complications.

Effective

The pain and function improvement for LinQ treatment is similar when compared to major studies with lateral triangular SI rods.

Our commitment to clinical excellence through evidence generation.

SECURE Prospective Study

12-month results

  • LinQ showed similar improvement in pain and function at 12 months as the iFuse device as demonstrated in their studies
  • VAS Pain Scores: 43.3 mean reduction at 12 months (from 76.2 mean to 32.6 mean) with 73.5% having ≥ 20 improvement
  • ODI Function Scores: 25.3 mean improvement at 12 months (from 52.4 mean to 26.9 mean) with 68.7% having ≥ 15 improvement
Read the Paper

LinQ Comparative Biomechanics Study

Compared to the lateral approach, 
posterior fusion with LinQ showed:

  • Similar performance in stabilizing the SI joint during flexion-extension motions
  • Superior performance in stabilizing the SI joint during lateral bending and axial rotation motions
Read the Paper

Pain Salvage Study

Salvage of Previous Pain Devices with LinQ

LinQ demonstrated the potential to rescue patients who have had inadequate pain relief from previous therapies, including:

  • Spinal cord stimulation
  • Interspinous spacer
  • Intrathecal drug delivery
  • Minimally invasive lumbar decompression

Average Patient-reported Pain Relief:

67.6%

Average Pain Relief in Failed Back Surgery Syndrome Patients:

76.5%

LinQ Real-world
Retrospective Study

Safety and Efficacy

LinQ demonstrated long-term safety and efficacy in
treating SI joint pain (avg. time after treatment of 612 days)

Avg. NRS Before LinQ:

6.98

Avg. NRS After LinQ:

3.06

Average Pain Relief

66.5%

NRS: Numeric Rating Scale for pain

Read the Paper

Additional Supporting Evidence

LinQ Studies

Clinical Outcomes for Minimally Invasive Sacroiliac Joint Fusion with Allograft using a Posterior Approach

An independent investigator-initiated retrospective analysis of 43 patients identified a mean VAS score reduction from 8.26 at baseline to 2.71 at 12 months and a statistically significant reduction in medication usage. No adverse events occurred.

SECURE Prospective Study 6-month Interim Results: LinQ Safety and Efficacy

At 6 months, a mean improvement of 34.9 was identified by a reduction in VAS and functional improvement was demonstrated by a mean reduction in ODI of 17.7. The posterior single-point transfixation is safe and efficacious for the treatment of sacroiliac joint dysfunction with statistical improvements in pain and function.

Lateral Salvage Study: Salvage of Failed Lateral SIJ Devices with LinQ

A total of 7 patients who had undergone lateral SIJ fusion were included in the study and underwent posterior SIJ fusion. We were able to show significant reductions in pain scores and opioid consumption, which suggests that minimally invasive posterior SIJ fusion using LinQ may be a viable treatment option to salvage pain relief in those with failed lateral SIJ devices. The mean patient-reported pain improvement following posterior fusion was 80%, with an average follow-up time of 10 months. Median morphine milliequivalents were 20 pre-procedure and 0 post-procedure.

LinQ Biomechanics Study

Our novel posterior approach presents a multifaceted mechanism for stabilizing the joint: first, by the reduction of the total range of motion in all planes of motion; second, by shifting the centers of the instantaneous axis of rotation towards the implant’s location in the predominant plane of motion, ensuring little to no motion at the implantation site, thus promoting fusion in this region.

Post-operative Management

Best Practices for Post-op Management of SIJ Fusion

SIJ fusion is a rapidly growing and evolving therapy with developing evidence to support its safety and efficacy. In the setting of a desired surgical outcome, safety and efficacy can be adversely impacted by poor post-operative care. The American Society of Pain and Neuroscience has created this best practice document in an effort to improve and standardize care in this critical time of patient recovery.

Diagnosis

Successful Diagnosis of SIJ Dysfunction

The diagnosis of SIJ pain is a multifaceted process that involves a careful assessment, including differentiating other pain generators in the region. This involves careful history-taking, appropriate physical examination, including provocative maneuvers, and diagnostic injections. Once the diagnosis is confirmed, long-term solutions may be considered, including recent advances in sacral lateral branch denervation and sacroiliac joint fusion.

A Review and Algorithm in the Diagnosis and Treatment of SIJ Pain

We have created a clearer diagnostic and treatment pathway to establish an algorithm for patients that can include conservative measures and interventional techniques once the diagnosis is identified.

Reviews

American Society of Pain and Neuroscience Best Practice (ASPN) Guideline for the Treatment of Sacroiliac Disorders

While the quantity of evidence is currently more robust with the lateral approach given its preexistence, available studies suggest that that the posterior approach has at least similar efficacy with a lower risk profile

Review of Current Evidence for Minimally Invasive Posterior Sacroiliac Joint Fusion

While the lateral or transiliac approach has been well published, the posterior and posterior oblique approach has been recently introduced as an alternative means of stabilization of the SIJ. Preliminary case series presented reveal consistent decreases in pain scores and low complication rates.

Back To Top
×Close search
Search